SCHEMBL8336318

SCHEMBL8336318

CCCCCCC(C)N(C(=O)NC)C(=O)C(C)c1ccc(OC)c(N=S(=O)=O)c1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ SMPD1 P17405 3/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ C5 P01031 1/20 0.33
▸ MMP1 P03956 2/20 0.32
▸ MMP9 P14780 2/20 0.32
▸ MMP13 P45452 2/20 0.32
▸ ADAM17 P78536 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8337752 0.99 SMN1; SMN2 (0.35) SMPD1SMN1; SMN2GAATDP1L3MBTL1
SCHEMBL8340001 0.96 SMN1; SMN2 (0.36) SMPD1SMN1; SMN2GAATDP1L3MBTL1
SCHEMBL8335608 0.93 SMPD1 (0.34) SMPD1SMN1; SMN2GAATDP1L3MBTL1
SCHEMBL8336029 0.92 TAS1R3 (0.33) SMN1; SMN2
SCHEMBL8338441 0.92 SMN1; SMN2 (0.34) SMPD1SMN1; SMN2GAATDP1L3MBTL1
SCHEMBL8338614 0.89 SMN1; SMN2 (0.35) SMPD1SMN1; SMN2GAATDP1L3MBTL1
SCHEMBL8339968 0.88 HIF1A (0.35) SMN1; SMN2
SCHEMBL8339172 0.87 SMN1; SMN2 (0.37) SMPD1SMN1; SMN2
SCHEMBL8389248 0.85 TAS1R3 (0.32) SMN1; SMN2
SCHEMBL8335997 0.85 SMPD1 (0.36) SMPD1SMN1; SMN2GAATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback